9 research outputs found
Recommended from our members
CellsDeepNet: A Novel Deep Learning-Based Web Application for the Automated Morphometric Analysis of Corneal Endothelial Cells
YesThe quantification of corneal endothelial cell (CEC) morphology using manual and semi-automatic software enables an objective assessment of corneal endothelial pathology. However, the procedure is tedious, subjective, and not widely applied in clinical practice. We have developed the CellsDeepNet system to automatically segment and analyse the CEC morphology. The CellsDeepNet system uses Contrast-Limited Adaptive Histogram Equalization (CLAHE) to improve the contrast of the CEC images and reduce the effects of non-uniform image illumination, 2D Double-Density Dual-Tree Complex Wavelet Transform (2DDD-TCWT) to reduce noise, Butterworth Bandpass filter to enhance the CEC edges, and moving average filter to adjust for brightness level. An improved version of U-Net was used to detect the boundaries of the CECs, regardless of the CEC size. CEC morphology was measured as mean cell density (MCD, cell/mm2), mean cell area (MCA, µm2), mean cell perimeter (MCP, µm), polymegathism (coefficient of CEC size variation), and pleomorphism (percentage of hexagonality coefficient). The CellsDeepNet system correlated highly significantly with the manual estimations for MCD (r = 0.94), MCA (r = 0.99), MCP (r = 0.99), polymegathism (r = 0.92), and pleomorphism (r = 0.86), with
Accelerated surgery versus standard care in hip fracture (HIP ATTACK) : an international, randomised, controlled trial
Background: Observational studies have suggested that accelerated surgery is associated with improved outcomes in patients with a hip fracture. The HIP ATTACK trial assessed whether accelerated surgery could reduce mortality and major complications. Methods: HIP ATTACK was an international, randomised, controlled trial done at 69 hospitals in 17 countries. Patients with a hip fracture that required surgery and were aged 45 years or older were eligible. Research personnel randomly assigned patients (1:1) through a central computerised randomisation system using randomly varying block sizes to either accelerated surgery (goal of surgery within 6 h of diagnosis) or standard care. The coprimary outcomes were mortality and a composite of major complications (ie, mortality and non-fatal myocardial infarction, stroke, venous thromboembolism, sepsis, pneumonia, life-threatening bleeding, and major bleeding) at 90 days after randomisation. Patients, health-care providers, and study staff were aware of treatment assignment, but outcome adjudicators were masked to treatment allocation. Patients were analysed according to the intention-to-treat principle. This study is registered at ClinicalTrials.gov (NCT02027896). Findings: Between March 14, 2014, and May 24, 2019, 27 701 patients were screened, of whom 7780 were eligible. 2970 of these were enrolled and randomly assigned to receive accelerated surgery (n=1487) or standard care (n=1483). The median time from hip fracture diagnosis to surgery was 6 h (IQR 4\u20139) in the accelerated-surgery group and 24 h (10\u201342) in the standard-care group (p<0\ub70001). 140 (9%) patients assigned to accelerated surgery and 154 (10%) assigned to standard care died, with a hazard ratio (HR) of 0\ub791 (95% CI 0\ub772 to 1\ub714) and absolute risk reduction (ARR) of 1% ( 121 to 3; p=0\ub740). Major complications occurred in 321 (22%) patients assigned to accelerated surgery and 331 (22%) assigned to standard care, with an HR of 0\ub797 (0\ub783 to 1\ub713) and an ARR of 1% ( 122 to 4; p=0\ub771). Interpretation: Among patients with a hip fracture, accelerated surgery did not significantly lower the risk of mortality or a composite of major complications compared with standard care. Funding: Canadian Institutes of Health Research